# DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

> **NCT01614366** · PHASE2 · COMPLETED · sponsor: **TSH Biopharm Corporation Limited** · enrollment: 111 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** AM 5 + DM 0
- **DRUG:** AM 5 + DM 2.5
- **DRUG:** AM 5 + DM 7.5
- **DRUG:** AM 5 + DM 30

## Key facts

- **NCT ID:** NCT01614366
- **Lead sponsor:** TSH Biopharm Corporation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614366, "DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01614366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
